Nuclear Oncology

You are here

Nuclear Oncology

 

Recent Headlines

A ‘nuclear scalpel’ may emerge from discovery of four new elements

Scientists from Japan, Russia and the U.S. have discovered four new chemical elements that, taken together, complete the seventh period of the periodic table of elements. And the first area of human endeavor to find a practical use for the expanded knowledge may be nuclear medicine.

Zecotek settles patent suit against Philips, Saint Gobain

Singapore-based Zecotek Photonics, makers of industrial imaging technologies, announced today that the company has settled a lawsuit brought against Philips and Saint Gobain over patent infringement regarding new PET detector technology.

FDG PET/ CT predicts survival in non-small cell lung cancer patients

A quantitative PET measurement known as total lesion glycolysis could help clinicians make informed prognoses for patients with a stage of non-small lung cancer, according to a study published online Dec. 18 in the Journal of Nuclear Medicine.

Additional PET/CT alters treatment, predicts survival for certain cancer patients

Oral cavity squamous cell carcinoma is a painful and debilitating cancer. Another PET/CT after surgery and before adjuvant therapy could improve survival for these patients, according to a study published in the Journal of Nuclear Medicine.

DOTATATE PET/CT changed treatment plans for 60% of NET patients

PET/CT with Ga-68 DOTATATE has been found to change treatment plans in a majority of patients receiving initial evaluation and subsequent staging of neuroendocrine tumors (NETs), according to the results of two referring physician surveys published Dec. 11 in the Journal of Nuclear Medicine.

Frost & Sullivan honors new Philips PET/CT

Philips Healthcare has won the title of the 2014 North America Award for Technology Innovation Leadership from the market research firm Frost & Sullivan based on the integrated technology of the Vereos digital PET/CT system, Frost & Sullivan officials announced Nov. 26.

Breast cancer model could usher in new generation of imaging, therapy

A trifecta of cells has been revealed to be the crux of breast cancer metastases. The discovery provides cutting-edge details that could revolutionize the development of diagnostic testing and therapeutic agents for breast cancer, officials at the Albert Einstein College of Medicine in New York announced yesterday.

The Evolution of SPECT

The evolution of SPECT imaging has taken many twists and turns as both equipment technology and new radiopharmaceuticals have been developed over the past decade.

Lightspeed: The Coming of Age of Proton Therapy

Proton therapy used to be the next-generation cancer treatment that was larger than life and too expensive for any institution other than the most cutting-edge research hospital.

Pancreatic Cancer: Molecular Imaging’s Increasing Role

Currently ranked the fourth-leading cause of cancer-related deaths in the U.S. and slated to move up the list to No. 2 in the next few years, pancreatic cancer has the highest mortality rate and among the poorest prognoses of all major cancers. 

Pages